Sildenafil Potentiates a cGMP-Dependent Pathway to Promote Melanoma Growth.
-
Dhayade S
Interfakultäres Institut für Biochemie, University of Tübingen, 72076 Tübingen, Germany.
-
Kaesler S
Department of Dermatology, University of Tübingen, 72076 Tübingen, Germany.
-
Sinnberg T
Department of Dermatology, University of Tübingen, 72076 Tübingen, Germany.
-
Dobrowinski H
Interfakultäres Institut für Biochemie, University of Tübingen, 72076 Tübingen, Germany.
-
Peters S
Interfakultäres Institut für Biochemie, University of Tübingen, 72076 Tübingen, Germany.
-
Naumann U
Hertie-Institut für klinische Hirnforschung, Abteilung Vaskuläre Neurologie, Labor für Molekulare Neuroonkologie, 72076 Tübingen, Germany.
-
Liu H
Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland.
-
Hunger RE
Department of Dermatology, Inselspital, University Hospital Bern, 3010 Bern, Switzerland.
-
Thunemann M
Interfakultäres Institut für Biochemie, University of Tübingen, 72076 Tübingen, Germany.
-
Biedermann T
Department of Dermatology, University of Tübingen, 72076 Tübingen, Germany; Department of Dermatology and Allergology, Technische Universität München, 80802 Munich, Germany.
-
Schittek B
Department of Dermatology, University of Tübingen, 72076 Tübingen, Germany.
-
Simon HU
Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland.
-
Feil S
Interfakultäres Institut für Biochemie, University of Tübingen, 72076 Tübingen, Germany.
-
Feil R
Interfakultäres Institut für Biochemie, University of Tübingen, 72076 Tübingen, Germany. Electronic address: robert.feil@uni-tuebingen.de.
Show more…
English
Sildenafil, an inhibitor of the cGMP-degrading phosphodiesterase 5 that is used to treat erectile dysfunction, has been linked to an increased risk of melanoma. Here, we have examined the potential connection between cGMP-dependent signaling cascades and melanoma growth. Using a combination of biochemical assays and real-time monitoring of melanoma cells, we report a cGMP-dependent growth-promoting pathway in murine and human melanoma cells. We document that C-type natriuretic peptide (CNP), a ligand of the membrane-bound guanylate cyclase B, enhances the activity of cGMP-dependent protein kinase I (cGKI) in melanoma cells by increasing the intracellular levels of cGMP. Activation of this cGMP pathway promotes melanoma cell growth and migration in a p44/42 MAPK-dependent manner. Sildenafil treatment further increases intracellular cGMP concentrations, potentiating activation of this pathway. Collectively, our data identify this cGMP-cGKI pathway as the link between sildenafil usage and increased melanoma risk.
-
Language
-
-
Open access status
-
gold
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/155299
Statistics
Document views: 16
File downloads: